Insights

Targeted Partnerships Leverage Novalent’s existing distribution partnerships with Buy Supply and NISSCO to expand channel reach and enter new regional markets, focusing on retailers and manufacturers that require durable antimicrobial protection.

Healthcare and FMCG Synergy Prioritize collaborations with consumer goods and healthcare-adjacent brands (e.g., food production, textiles, personal care) that require long-lasting surface protection and skin-friendly formulations to differentiate products in crowded categories.

Channel Expansion Capitalize on the company’s multi-location sales footprint by targeting multinational brands with global manufacturing and distribution networks, offering consistent antimicrobial performance across facilities and products.

Strategic Advisory Utilize advisory board credibility and academic affiliations to open conversations with sustainability and R&D leaders, positioning Novalent as a trusted partner for long-lasting germ protection and compliance-ready solutions.

Growth Financing Signals Align outreach with growth-ready storytelling around recent funding and revenue potential, targeting investors and strategic buyers looking for scalable antimicrobial technology and US-based manufacturing advantages.

Similar companies to Novālent Ltd.

Novālent Ltd. Tech Stack

Novālent Ltd. uses 8 technology products and services including Hotjar, WordPress, Shopify, and more. Explore Novālent Ltd.'s tech stack below.

  • Analytics
  • Content Management System
  • E-commerce
  • Platform As A Service
  • PHP
    Programming Languages
  • Video Players
  • Nginx
    Web Servers
  • prettyPhoto
    Web Tools And Plugins

Novālent Ltd.'s Email Address Formats

Novālent Ltd. uses at least 1 email format:
Novālent Ltd. Email FormatsExamplePercentage
First.Last@novalent.comJohn.Doe@novalent.com
100%

Frequently Asked Questions

What is Novālent Ltd.'s official website and social media links?

Minus sign iconPlus sign icon
Novālent Ltd.'s official website is novalent.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Novālent Ltd. generate?

Minus sign iconPlus sign icon
As of November 2026, Novālent Ltd.'s annual revenue is estimated to be $1M - $10M.

What is Novālent Ltd.'s NAICS code?

Minus sign iconPlus sign icon
Novālent Ltd.'s NAICS code is 325 - Chemical Manufacturing.

How many employees does Novālent Ltd. have currently?

Minus sign iconPlus sign icon
As of November 2026, Novālent Ltd. has approximately 8 employees across 3 continents, including North America, Europe and Oceania. Key team members include Vice President , Sales: B. M., Key Account Manager: B. K. and Serviceingenjör / Sälj: L. A. Explore Novālent Ltd.'s employee directory with LeadIQ.

What industry does Novālent Ltd. belong to?

Minus sign iconPlus sign icon
Novālent Ltd. operates in the Chemical Manufacturing industry.

What technology does Novālent Ltd. use?

Minus sign iconPlus sign icon
Novālent Ltd.'s tech stack includes Hotjar, WordPress, Shopify, WP Engine, PHP, Vimeo, Nginx and prettyPhoto.

What is Novālent Ltd.'s email format?

Minus sign iconPlus sign icon
Novālent Ltd.'s email format typically follows the pattern of First.Last@novalent.com. Find more Novālent Ltd. email formats with LeadIQ.

How much funding has Novālent Ltd. raised to date?

Minus sign iconPlus sign icon
As of November 2026, Novālent Ltd. has raised $11M in funding. The last funding round occurred on Nov 30, 2021 for $11M.
Novālent Ltd. logo

Novālent Ltd.

Chemical ManufacturingNorth Carolina, United States2-10 Employees

Novālent Ltd. is a Greensboro, North Carolina-based chemical manufacturing and biotechnology engineering firm focused on surface- and skin-facing antimicrobial protection. Its technology uses a patented, non-toxic monomolecular layer that can continuously kill germs on surfaces for up to 90 days and on human skin for up to 24 hours after application, offering ongoing sanitization without frequent reapplication. The company serves a corporate customer base, including brands like PepsiCo, Pilgrims, and HanesBrands, and has established distribution and partnerships to reach multiple channels. Novālent operates within the US biotechnology engineering sector and positions itself as an innovator providing long-lasting antimicrobial solutions for commercial use. In recent developments, the firm announced partnerships to broaden its distribution network and channel reach.

Section iconCompany Overview

NAICS Code
325 - Chemical Manufacturing
Employees
2-10

Section iconFunding & Financials

  • $11M

    Novālent Ltd. has raised a total of $11M of funding over 1 rounds. Their latest funding round was raised on Nov 30, 2021 in the amount of $11M.

  • $1M - $10M

    Novālent Ltd.'s revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.